U.S. Prosthetic Heart Valve Market Thumbnail Image

2024

U.S. Prosthetic Heart Valve Market

U.S. Prosthetic Heart Valve Market Size, Share, Competitive Landscape and Trend Analysis Report, by Product, : Opportunity Analysis and Industry Forecast, 2024-2033

LS : Medical Devices & Supplies

Select an option
Author's: Pritee Pawar | Roshan Deshmukh
Publish Date:

Get Sample to Email

U.S. Prosthetic Heart Valve Market Research, 2033

The U.S. prosthetic heart valve market size was valued at $3.2 billion in 2023, and is projected to reach $8.9 billion by 2033, growing at a CAGR of 10.7% from 2024 to 2033. A prosthetic heart valve is an artificial device implanted in the heart to replace a damaged or diseased natural valve, ensuring proper blood flow through the heart and to the rest of the body. In the U.S., prosthetic heart valves are used to treat conditions such as aortic stenosis and mitral regurgitation. These valves can be mechanical, made from durable materials such as metal or carbon, or bioprosthetic, derived from animal tissues. The U.S. prosthetic heart valve market size is driven by an aging population, advancements in minimally invasive procedures, and increasing awareness of cardiovascular diseases. 

U.S. Prosthetic Heart Valve Market

Key Market Dynamics 

The U.S. prosthetic heart valve market growth is predominantly driven by factors such as aging population, increasing prevalence of valvular heart diseases, advancements in technology, greater awareness and early diagnosis, a favorable regulatory and reimbursement environment, the rising demand for minimally invasive procedures, and ongoing R&D efforts. For instance, according to American College of Cardiology 2021, more than 5 million people are diagnosed with valvular heart diseases (VHD) each year in the U.S. Thus, rise in prevalence of valvular heart diseases (VHD) drives the market growth. In addition, rise in geriatric population led to rise in incidence of cardiovascular diseases, including valvular heart diseases thereby supports the market growth, Conditions such as aortic stenosis and mitral regurgitation are more common in older adults, leading to an increased demand for prosthetic heart valves. For instance, according to the Administration for Community Living (ACL) , in the U.S., Americans 65 and older numbered 57.8 million in 2022. They represented 17.3% of the population. Thus, rise in geriatric population drive the growth during U.S. prosthetic heart valve market forecast period. 

Further, the U.S. prosthetic heart valve market trends includes the growing awareness of valvular heart diseases and the importance of early diagnosis and treatment. Early diagnosis allows for timely intervention, often leading to better patient outcomes. As more healthcare providers emphasize the importance of regular cardiovascular screenings, the identification of candidates for prosthetic heart valve replacement is expected to increase, further fueling market growth. However, the high cost of devices and procedures, potential complications such as valve deterioration or thrombosis, and stringent regulatory approval processes are the factors which may restrain the U.S. prosthetic heart valve market growth. 

On the contrary, growing adoption of transcatheter aortic valve replacement (TAVR) procedures, which provide a minimally invasive alternative to open-heart surgery thereby provides market opportunity. The development of next-generation valves with enhanced durability and reduced complications presents significant market potential. Additionally, increased investment in R&D for innovative valve technologies, coupled with favorable regulatory support and reimbursement policies, can also drive market expansion. 

Market Segmentation 

The U.S. prosthetic heart valve market size is segmented on the basis of product. On the basis of product, the market is categorized into mechanical heart valve, tissue heart valve, and transcatheter heart valve. The tissue heart valve segment is further classified into stented tissue heart valve and stent less tissue heart valve. The transcatheter heart valve segment generated the largest revenue in U.S. prosthetic heart valve market share in 2023, owing to its minimally invasive nature, associated benefits, surge in cardiovascular disorders, and rise in demand of cardiac valve replacement therapy. In addition, rise in advancements in transcatheter heart valve technology, such as improved valve designs and delivery systems, have further enhanced procedural outcomes and expanded the eligible patient population. As a result, the transcatheter heart valve segment continues to lead the U.S. prosthetic heart valve industry. 

Industry Trends 

  • According to Centers for Disease Control and Prevention (CDC) 2022, 40, 000 babies were born with congenital heart defect every year in the U.S. Thus, patients with congenital heart defects require surgical intervention to repair or replace the damaged valve, which creates a significant demand for prosthetic heart valves in the U.S. 

Competitive Landscape 

The key players operating in the U.S. Prosthetic heart valve market are Abbott Laboratories, Artivion, Inc, Anteris Technologies Ltd, Boston Scientific Corporation, Edward Lifesciences Corporation, JenaValve Technology, Inc., Colibri Heart Valve, Medtronic plc, Meril Life Sciences Pvt. Ltd., and ShockWave Medical, Inc. These players have adopted various developmental strategies to stay competitive in the market. For instance, in February 2024, Edwards Lifesciences Corporation announced the company’s EVOQUE tricuspid valve replacement system is the first transcatheter therapy to receive U.S. Food and Drug Administration (FDA) approval for the treatment of tricuspid regurgitation (TR) . The EVOQUE system is indicated for the improvement of health status in patients with symptomatic severe TR despite optimal medical therapy (OMT) , for whom tricuspid valve replacement is deemed appropriate by a heart team. 

Key Benefits for Stakeholders

  • Enable informed decision-making process and offer market analysis based on current market situation and estimated future trends.
  • Analyze the key strategies adopted by major market players in U.S. prosthetic heart valve industry.
  • Assess and rank the top factors that are expected to affect the growth of U.S. prosthetic heart valve market.
  • Top Player positioning provides a clear understanding of the present position of market players.
  • Detailed analysis of the U.S. prosthetic heart valve market segmentation assists to determine the prevailing market opportunities.
  • Identify key investment pockets for various offerings in the market.

U.S. Prosthetic Heart Valve Market Report Highlights

Aspects Details
icon_1
Market Size By 2033

USD 8.9 Billion

icon_2
Growth Rate

CAGR of 10.7%

icon_3
Forecast period

2024 - 2033

icon_4
Report Pages

90

icon_5
By Product
  • Tissue Heart Valve
    • Stented Tissue Heart Valve
    • Stentless Tissue Heart Valve
  • Mechanical Heart Valve
  • Transcatheter Heart Valve
icon_6
Key Market Players

Edward Lifesciences Corporation, Anteris Technologies Ltd, Medtronic plc, Artivion, Inc, ShockWave Medical, Inc., Boston Scientific Corporation, JenaValve Technology, Inc., Abbott Laboratories, Colibri Heart Valve, Meril Life Sciences Pvt. Ltd.

Author Name(s) : Pritee Pawar | Roshan Deshmukh
Frequently Asked Questions?

The U.S. prosthetic heart valve market is projected to grow at a CAGR of 10.7 % from 2024 to 2033.

Abbott Laboratories, Artivion, Inc, Anteris Technologies Ltd, Boston Scientific Corporation, Edward Lifesciences Corporation, JenaValve Technology, Inc., Colibri Heart Valve, Medtronic plc, Meril Life Sciences Pvt. Ltd., ShockWave Medical, Inc. are the leading players in U.S. Prosthetic Heart Valve Market

1. Enable informed decision-making process and offer market analysis based on current market situation and estimated future trends. 2. Analyze the key strategies adopted by major market players in U.S. prosthetic heart valve market. 3. Assess and rank the top factors that are expected to affect the growth of U.S. prosthetic heart valve market. 4. Top Player positioning provides a clear understanding of the present position of market players. 5. Detailed analysis of the U.S. prosthetic heart valv

For analysis, the U.S. prosthetic heart valve market is segmented on the basis of product.

Loading Table Of Content...

U.S. Prosthetic Heart Valve Market

Opportunity Analysis and Industry Forecast, 2024-2033